323 related articles for article (PubMed ID: 15030417)
1. Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
Burns JL; Sears SF; Sotile R; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
J Cardiovasc Electrophysiol; 2004 Mar; 15(3):286-91. PubMed ID: 15030417
[TBL] [Abstract][Full Text] [Related]
2. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.
Newman DM; Dorian P; Paquette M; Sulke N; Gold MR; Schwartzman DS; Schaaf K; Wood K; Johnson L;
Am Heart J; 2003 May; 145(5):841-6. PubMed ID: 12766741
[TBL] [Abstract][Full Text] [Related]
3. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
4. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey.
Burns JL; Serber ER; Keim S; Sears SF
J Cardiovasc Electrophysiol; 2005 Apr; 16(4):384-90. PubMed ID: 15828880
[TBL] [Abstract][Full Text] [Related]
5. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
6. Understanding atrial symptom reports: objective versus subjective predictors.
Sears SF; Serber ER; Alvarez LG; Schwartzman DS; Hoyt RH; Ujhelyi MR
Pacing Clin Electrophysiol; 2005 Aug; 28(8):801-7. PubMed ID: 16105008
[TBL] [Abstract][Full Text] [Related]
7. Quality of life after use of the patient activated atrial defibrillator.
Spurrell P; Mitchell A; Kamalvand K; Sulke N
Int J Clin Pract; 2003; 57(1):30-4. PubMed ID: 12587939
[TBL] [Abstract][Full Text] [Related]
8. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
9. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
[TBL] [Abstract][Full Text] [Related]
10. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients.
Pedersen SS; Spindler H; Johansen JB; Mortensen PT; Sears SF
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1168-77. PubMed ID: 18834469
[TBL] [Abstract][Full Text] [Related]
11. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
[TBL] [Abstract][Full Text] [Related]
12. Come see the softer side of clinical outcomes: Quality-of-life measures in implanted defibrillator trials.
Groh WJ; Bhakta D; Lowe MR; Bennett SJ
J Cardiovasc Electrophysiol; 2004 Mar; 15(3):292-4. PubMed ID: 15030418
[No Abstract] [Full Text] [Related]
13. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
[TBL] [Abstract][Full Text] [Related]
14. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in anxiety and concerns about the cardioverter defibrillator.
Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
[TBL] [Abstract][Full Text] [Related]
16. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program.
Kuhl EA; Sears SF; Vazquez LD; Conti JB
J Cardiovasc Nurs; 2009; 24(3):225-31. PubMed ID: 19390340
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients.
Johansen JB; Pedersen SS; Spindler H; Andersen K; Nielsen JC; Mortensen PT
Europace; 2008 May; 10(5):545-51. PubMed ID: 18378633
[TBL] [Abstract][Full Text] [Related]
18. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
[TBL] [Abstract][Full Text] [Related]
19. Nitrous oxide sedation reduces discomfort caused by atrial defibrillation shocks.
Ujhelyi M; Hoyt RH; Burns K; Fishman RS; Musley S; Silverman MH
Pacing Clin Electrophysiol; 2004 Apr; 27(4):485-91. PubMed ID: 15078402
[TBL] [Abstract][Full Text] [Related]
20. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]